Dapagliflozin 10 Mg Tablets 10 mg Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 10 mg
Reference Brands: Forxiga(US & EU), Edistride (India), Dapazin (EU)
Category: Diabetes
Dapagliflozin is an SGLT2 inhibitor that reduces glucose reabsorption in the kidneys, promoting urinary glucose excretion. It improves glycemic control, supports weight loss, lowers blood pressure, and reduces the risk of heart failure and kidney disease progression. It offers once-daily oral dosing with cardiovascular and renal protective benefits.
Product Description:
Dapagliflozin, an SGLT2 inhibitor, is approved in both the USA and EU for treating type 2 diabetes, heart failure, and chronic kidney disease. In the USA, it is marketed as Farxiga®, approved via an NDA under 21 CFR, requiring robust safety labeling for risks like ketoacidosis and UTIs. In the EU, it is approved as Forxiga® through the centralized procedure by the EMA, with CTD-format submission, RMP, PSURs, and strict pharmacovigilance. Manufacturers must comply with GMP and post-marketing obligations. For regulatory consulting, global B2B sourcing, or dossier support, visit PharmaTradz.com.
Dapagliflozin 10 Mg Tablets — third party manufacturing & bulk supply
Dapagliflozin 10 Mg Tablets 10 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Dapagliflozin 10 Mg Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Dapagliflozin 10 Mg Tablets →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Dapagliflozin is used to manage Type 2 diabetes mellitus by lowering blood glucose levels. It is also indicated to reduce the risk of hospitalization for heart failure and slow the progression of chronic kidney disease in patients with or without diabetes.
Dapagliflozin is a synthetic small-molecule drug and an SGLT2 (sodium-glucose co-transporter 2) inhibitor, which works by preventing glucose reabsorption in the kidneys, promoting its excretion through urine.
The main trade name for dapagliflozin is Farxiga (USA) and Forxiga (EU).
Dapagliflozin is manufactured by AstraZeneca, a global biopharmaceutical company.
The generic name is Dapagliflozin.
Brand names include Farxiga (USA) and Forxiga (EU, India, and other regions).
Dapagliflozin is manufactured in the United States and Europe and distributed globally, including the USA, EU, India, Japan, and other countries.
Related Products
Pioglitazone Hydrochloride 150Mg Tablet
Strength:
15 mg, 30 mg, 45 mg
Form: Tablets
Reference Brands: Actos (USA)
View Details
Nateglinide
Strength:
60 mg, 120 mg, 180 mg
Form: Tablets
Reference Brands: Starlix (USA)
View Details
Miglitol
Strength:
25 mg, 50 mg, 100 mg
Form: Tablets
Reference Brands: Glyset (USA), Diastabol (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
